Robert Hofmeister

Company: Myeloid Therapeutics

Job title: Chief Scientific Officer

Seminars:

Keynote Presentation: Highlighting Myeloid’s Groundbreaking Clinical Experience with the First In Vivo CARs Applied to Humans 11:00 am

Exploring CAR designs to target myeloid, NK, and T cells to enhance therapeutic precision when combating solid tumors  Leveraging LNP technology to create a scalable, accessible, cost-effective platform  Uncovering first-in-class phase 1 clinical trial data, demonstrating safety promising clinical benefits Read more

day: Day One